EPI-SK14

N/A

Report date: 2022/11/07 19:48:37

Base Information

Drug NameEPI-SK14
Drug Alias NameArtemether topical - EpiPharmEPI-SK14
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSarcoplasmic/endoplasmic reticulum calcium ATPase 1 inhibitorsSarcoplasmic/endoplasmic reticulum calcium ATPase 2 inhibitors
TargetsSarcoplasmic/endoplasmic reticulum calcium ATPase 1Sarcoplasmic/endoplasmic reticulum calcium ATPase 2
Therapy Area/IndicationsKeratosis, Seborrheic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEpipharm AG
China Registration ClassN/A

Develop Information

Active CompaniesEpipharm AG
Inactive CompaniesN/A
Active IndicationsKeratosis, Seborrheic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A